Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425684 · ClinicalTrials.gov registry record
Brain Circuits in Schizophrenia and Smoking
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 837
- Enrollment target
NCT01425684 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 837 participants.
The verdict
NCT01425684 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 837 participants
- Enrollment target
Study Summary
The principle aim of the project is to identify the key brain circuits associated with smoking and especially smoking in high risk population. The investigators hope that the study will provide concrete biomarkers for new therapeutic development and ultimately reducing the smoking related health burden.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 837 participants |
| Start Date | 2010-12-20 |
| Est. Completion | 2021-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01425684
The ClinicalTrials.gov registry entry for NCT01425684 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 837 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01425684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01425684 about?
NCT01425684 is a clinical study titled "Brain Circuits in Schizophrenia and Smoking". The principle aim of the project is to identify the key brain circuits associated with smoking and especially smoking in high risk population. The investigators hope that the study will provide concrete biomarkers for new therapeutic development and ultimately reducing the smoking related health bur...
What is the current status of trial NCT01425684?
This trial is currently completed. The enrollment target is 837 participants. The study started on 2010-12-20. Estimated completion is 2021-04.
Who is sponsoring clinical trial NCT01425684?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.